Description
PHARMACY COMPLIANCE SOFTWARE
Base award description: :IGF::OT::IGF: PHARMACY COMPLIANCE SOFTWARE
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-10-01+$38,437= $38,437
- Mod P000012019-02-27+$0= $38,437
- Mod P000022019-10-01+$10,784= $49,221
- Mod P000032020-10-01+$10,784= $60,005
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-10-01 | +$38,437 | $38,437 | :IGF::OT::IGF: PHARMACY COMPLIANCE SOFTWARE |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2019-02-27 | +$0 | $38,437 | :IGF::OT::IGF: PHARMACY COMPLIANCE SOFTWARE |
| Mod P00002· EXERCISE AN OPTION | 2019-10-01 | +$10,784 | $49,221 | PHARMACY COMPLIANCE SOFTWARE |
| Mod P00003· EXERCISE AN OPTION | 2020-10-01 | +$10,784 | $60,005 | PHARMACY COMPLIANCE SOFTWARE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D48FNWJCJ5H5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026F0037 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $364,000 | FY2026 |
| 36C26026F0019 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $111,000 | FY2026 |
| 36C26026F0015 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $120,000 | FY2026 |
| 36C26025F0153 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $97,176 | FY2025 |
| 36C26025F0037 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C26325F0017 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $103,293 | FY2025 |
Other recipients under D317 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24820F0271 | FOUR POINTS TECHNOLOGY, L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $162,869 | FY2020 |
| 36C24820P1354 | EBSCO INDUSTRIES INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $41,226 | FY2020 |
| 36C24820P1090 | OVID TECHNOLOGIES, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $67,991 | FY2020 |
| 36C24820P0011 | CHARTER COMMUNICATIONS HOLDINGS LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $9,440 | FY2020 |
| 36C24819F0387 | ATT MOBILITY LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $27,120 | FY2019 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24819P0008_3600_-NONE-_-NONE- · retrieved 2026-09-26.